1
|
Nalluri LP, Popuri SR, Lee CH, Terbish N. Synthesis of biopolymer coated functionalized superparamagnetic iron oxide nanoparticles for the pH-sensitive delivery of anti-cancer drugs epirubicin and temozolomide. INT J POLYM MATER PO 2021. [DOI: 10.1080/00914037.2020.1785449] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Affiliation(s)
- Lakshmi P. Nalluri
- Department of Environmental Engineering, Da-Yeh University, Changhua, R.O.C., Taiwan
| | - Srinivasa R. Popuri
- Department of Biological and Chemical Sciences, The University of the West Indies, Barbados, West Indies
| | - Ching-Hwa Lee
- Department of Environmental Engineering, Da-Yeh University, Changhua, R.O.C., Taiwan
| | - Narangarav Terbish
- Department of Environmental Engineering, Da-Yeh University, Changhua, R.O.C., Taiwan
| |
Collapse
|
2
|
Li X, Zou Q, Zhang J, Zhang P, Zhou X, Yalamarty SSK, Liang X, Liu Y, Zheng Q, Gao J. Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer. Int J Nanomedicine 2020; 15:6791-6811. [PMID: 32982234 PMCID: PMC7494236 DOI: 10.2147/ijn.s260477] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2020] [Accepted: 08/26/2020] [Indexed: 12/19/2022] Open
Abstract
PURPOSE Folic acid and cyclic arginylglycylaspartic acid peptides were introduced to the surface of negatively charged lipid-coated hybrid polydopamine-cysteine cores for the delivery of epirubicin (EPI) (E/PCF-NPs). The combined chemo-photothermal therapy using E/PCF-NPs for triple-negative breast cancer was evaluated. MATERIALS AND METHODS The temperature elevation and thermal toxicity of nanoparticles were studied. The morphology and properties of E/PCF-NPs were characterized by transmission electron microscopy, scanning electron microscopy, and atomic force microscopy. Physicochemical properties, including particle size, zeta potential, drug loading, entrapment efficiency (EE%), stability and in vitro release, were determined. The cell viability, reactive oxygen species (ROS) levels, ratios of oxidized nicotinamide adenine dinucleotide to its reduced form (NAD+/NADH), apoptosis assays, and cellular uptake of E/PCF-NPs were determined on 4T1 cells. Pharmacokinetic studies and tissue distributions were performed and detected by an ultra-high performance liquid chromatography/mass spectrometry system. The antitumor effects of E/PCF-NPs under near-infrared (NIR) laser irradiation were also evaluated. RESULTS The sphere-like morphology of E/PCF-NPs showed a high EE%, uniform size of 106.7 nm, remarkable stability, and highly improved cytotoxicity under NIR laser, when compared to that of photothermal treatment alone. In vitro release of EPI from E/PCF-NPs was pH sensitive, and a greater response was achieved under NIR laser irradiation. Compared to chemotherapy or photothermal treatment alone, the combined treatment in vitro significantly inhibited the survival rate of 4T1 cells to 17.7%, induced ROS generation, and reduced NAD+/NADH significantly. Treatment with E/PCF-NPs under irradiation induced 4T1 cell apoptosis in approximately 93.6% cells. In vitro cellular uptake of E/PCF-NPs was time-dependent. The long-circulating and higher tumor accumulation of E/PCF-NPs resulted in complete ablation of breast tumor tissue through the enhanced photothermal effect by NIR laser irradiation-mediated cell apoptosis. CONCLUSION E/PCF-NPs show enhanced anti-cancer effects due to synergistic effects of chemotherapy with photothermal therapy and may be potential therapeutic agents for cancer treatment.
Collapse
Affiliation(s)
- Xiang Li
- State Key Laboratory of Innovative Drug and Efficient Energy-Saving Pharmaceutical Equipment, Jiangxi University of Traditional Chinese Medicine, Nanchang330006, Jiangxi, People’s Republic of China
| | - Qian Zou
- State Key Laboratory of Innovative Drug and Efficient Energy-Saving Pharmaceutical Equipment, Jiangxi University of Traditional Chinese Medicine, Nanchang330006, Jiangxi, People’s Republic of China
| | - Jing Zhang
- Key Laboratory of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang330004, Jiangxi, People’s Republic of China
| | - Peng Zhang
- Key Laboratory of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang330004, Jiangxi, People’s Republic of China
| | - Xiong Zhou
- State Key Laboratory of Innovative Drug and Efficient Energy-Saving Pharmaceutical Equipment, Jiangxi University of Traditional Chinese Medicine, Nanchang330006, Jiangxi, People’s Republic of China
| | | | - Xinli Liang
- Key Laboratory of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang330004, Jiangxi, People’s Republic of China
| | - Yali Liu
- College of Science and Technology, Jiangxi University of Traditional Chinese Medicine, Nanchang330004, Jiangxi, People’s Republic of China
| | - Qin Zheng
- Key Laboratory of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang330004, Jiangxi, People’s Republic of China
| | - Jianqing Gao
- Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou310058, Zhejiang, People’s Republic of China
| |
Collapse
|
3
|
Perveen K, Masood F, Hameed A. Preparation, characterization and evaluation of antibacterial properties of epirubicin loaded PHB and PHBV nanoparticles. Int J Biol Macromol 2020; 144:259-266. [DOI: 10.1016/j.ijbiomac.2019.12.049] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2019] [Revised: 11/30/2019] [Accepted: 12/05/2019] [Indexed: 12/31/2022]
|
4
|
Zhang L, Li G, Gao M, Liu X, Ji B, Hua R, Zhou Y, Yang Y. RGD-peptide conjugated inulin-ibuprofen nanoparticles for targeted delivery of Epirubicin. Colloids Surf B Biointerfaces 2016; 144:81-89. [PMID: 27070055 DOI: 10.1016/j.colsurfb.2016.03.077] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2015] [Revised: 03/16/2016] [Accepted: 03/26/2016] [Indexed: 10/22/2022]
Abstract
Recently, chemotherapy-based polymeric nanoparticles have been extensively investigated for solid tumor treatment. Tumor targeted nanoparticles demonstrated great potential for improved accumulation in the tumor tissue, superior anticancer activity and reduced side effects. Thus, inulin-ibuprofen polymer was synthesized by esterification between inulin and ibuprofen, and RGD targeted epirubicin (EPB) loaded nanoparticles were prepared by the self-assembly of inulin-ibuprofen polymer and in situ encapsulation of EPB. RGD conjugated EPB loaded nanoparticles were characterized by dynamic light scattering (DLS) and transmission electron microscope (TEM). The EPB release from the nanoparticles showed pH-dependent profile and accelerated by the decreased pH value, which would favor the effective drug delivery in vivo. Intracellular uptake analysis suggested that RGD conjugated nanoparticles could be easily internalized by the cancer cells. In vitro cytotoxicity revealed that RGD conjugated EPB loaded nanoparticles exhibited the better antitumor efficacy compared with non-conjugated nanoparticles. More importantly, RGD conjugated EPB loaded nanoparticles showed superior anticancer effects and reduced toxicity than free EPB and non-conjugated nanoparticles by in vivo antitumor activity, EPB biodistribution and histology analysis.
Collapse
Affiliation(s)
- Luzhong Zhang
- Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong 226001, China; Hand Surgery Research Center, Department of Hand Surgery, Affiliated Hospital of Nantong University, Nantong 226001, China
| | - Guicai Li
- Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong 226001, China
| | - Ming Gao
- Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong 226001, China
| | - Xin Liu
- Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong 226001, China
| | - Bing Ji
- Medical College, Nantong University, Nantong 226001, China
| | - Ruheng Hua
- Medical College, Nantong University, Nantong 226001, China
| | - Youlang Zhou
- Hand Surgery Research Center, Department of Hand Surgery, Affiliated Hospital of Nantong University, Nantong 226001, China.
| | - Yumin Yang
- Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong 226001, China.
| |
Collapse
|
5
|
Yang B, Luo L, Ma Y, Chen C, Chen X, Cai C. Hydrophilic Magnetite Nanoparticles Enhance Anticancer Activity of Anthracyclines In Vitro. Aust J Chem 2016. [DOI: 10.1071/ch16074] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
A novel method for enhancing the anticancer activity of anthracyclines in vitro was proposed by using hydrophilic magnetic nanoparticles. Citric acid-coated magnetite nanoparticles Fe3O4 (nano-Fe3O4-CA) interacted with anthracyclines by electrostatic and hydrophobic forces, resulting in the formation of aggregates (nano-Fe3O4-CA-drug). The aggregate was studied by resonance light scattering and fluorescence spectroscopy. The results indicated that in comparison with anthracyclines, the nano-Fe3O4-CA-drug showed high activity towards incorporation in the DNA chain. Furthermore, the cytotoxicity of nano-Fe3O4-CA-drug was investigated by cytotoxicity experiment and cell morphology study. The results confirmed that the nano-Fe3O4-CA-drug could inhibit the growth of cells more effectively than the drug alone. In conclusion, usage of nano-Fe3O4-CA affords reduction of the dosage of anthracyclines in vitro.
Collapse
|
6
|
Kumar CS, Mahesh A, Antoniraj MG, Vaidevi S, Ruckmani K. Ultrafast synthesis of stabilized gold nanoparticles using aqueous fruit extract of Limonia acidissima L. and conjugated epirubicin: targeted drug delivery for treatment of breast cancer. RSC Adv 2016. [DOI: 10.1039/c6ra01482h] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
Abstract
Green synthesis of AuNPs using extract ofLimonia acidissimaL. as a reducing agent. Epirubicin was successfully loaded on folic acid–AuNPs. This formulation revealed better site specific delivery of epirubicin to MCF-7 cells.
Collapse
Affiliation(s)
- C. Senthil Kumar
- Department of Pharmaceutical Technology
- Anna University BIT Campus
- Tiruchirappalli-620024
- India
| | - Ayyavu Mahesh
- School of Biological Sciences
- Madurai Kamaraj University
- Madurai 625021
- India
| | - M. Gover Antoniraj
- Department of Pharmaceutical Technology
- Anna University BIT Campus
- Tiruchirappalli-620024
- India
| | - S. Vaidevi
- National Facility for Drug Development for Academia
- Pharmaceutical and Allied Industries (NFDD)
- Anna University, BIT Campus
- Tiruchirappalli-620024
- India
| | - K. Ruckmani
- Department of Pharmaceutical Technology
- Anna University BIT Campus
- Tiruchirappalli-620024
- India
- National Facility for Drug Development for Academia
| |
Collapse
|
7
|
Di-Wen S, Pan GZ, Hao L, Zhang J, Xue QZ, Wang P, Yuan QZ. Improved antitumor activity of epirubicin-loaded CXCR4-targeted polymeric nanoparticles in liver cancers. Int J Pharm 2015; 500:54-61. [PMID: 26748365 DOI: 10.1016/j.ijpharm.2015.12.066] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2015] [Revised: 12/15/2015] [Accepted: 12/27/2015] [Indexed: 10/22/2022]
Abstract
A liver-targeted drug delivery system (CX-EPNP) composed of PLGA/TPGS was prepared and characterized. The surface of nanoparticle was conjugated with LFC131 peptide to increase the specific interaction of carrier with CXCR4 overexpressing liver cancers to enhance the Epirubicin (EPI) delivery to tumors. The particles were nanosized with size than 150 nm and portrayed a sustained release kinetics suggesting its suitability for cancer targeting. The in vitro cell uptake results showed that the introduction of LFC131 to the nanoparticles could increase significantly the affinity to human hepatic carcinoma cells (HepG2) with approximately a 3-fold improvement in cellular uptake than non-targeted one. A specific receptor-mediated uptake was observed by confocal laser scanning microscopy. In addition, CX-EPNP showed remarkable cytotoxicity towards HepG2 cells, and could effectively inhibit tumor growth. The more significant EPI accumulation from CX-EPNP in the cancer cells gave rise to the enhanced EPI cytotoxicity and cell apoptosis. The CX-EPNP distributed mostly in the xenograft tumor after intravenous administration to mice and adequately remained in the blood for at least 24h. It seemed that CX-EPNP upon intravenous injection avoided rapid recognition by Kupffer cells and adequately remained in the blood. These findings suggest that CX-EPNP could effectively inhibit the growth of liver tumors in situ and could potentially reduce the systemic side effects. However, extensive investigation is still needed to assess the possible applications of the CX-EPNP in humans.
Collapse
Affiliation(s)
- Sun Di-Wen
- Department of Hepatobiliary Surgery, Shengli Oilfield Central Hospitial, 31 Jinan Road, Dongying, Shandong Province 257000, PR China
| | - Guo-Zheng Pan
- Department of Hepatobiliary Surgery, Shengli Oilfield Central Hospitial, 31 Jinan Road, Dongying, Shandong Province 257000, PR China
| | - Long Hao
- Department of Hepatobiliary Surgery, Shengli Oilfield Central Hospitial, 31 Jinan Road, Dongying, Shandong Province 257000, PR China
| | - Jian Zhang
- Department of Hepatobiliary Surgery, Shengli Oilfield Central Hospitial, 31 Jinan Road, Dongying, Shandong Province 257000, PR China
| | - Qing-Ze Xue
- Department of Hepatobiliary Surgery, Shengli Oilfield Central Hospitial, 31 Jinan Road, Dongying, Shandong Province 257000, PR China
| | - Peng Wang
- Department of Hepatobiliary Surgery, Shengli Oilfield Central Hospitial, 31 Jinan Road, Dongying, Shandong Province 257000, PR China
| | - Qing-Zhong Yuan
- Department of Hepatobiliary Surgery, Shengli Oilfield Central Hospitial, 31 Jinan Road, Dongying, Shandong Province 257000, PR China.
| |
Collapse
|